Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Los Angeles Jewish Home continues to meet nursing shortage in the country

While the healthcare industry bemoans a severe nursing shortage and sociologists warn of a growing health crisis amidst an aging population, the Los Angeles Jewish Home has continued to meet that challenge with its second graduating class from its innovative Annenberg School of Nursing.

24 Oct 2009

Eurogentec to acquire Anaspec, a private proteomics company in California

Eurogentec S.A. (“Eurogentec”) announces today a final agreement for the acquisition of AnaSpec, Inc. (“AnaSpec” or the “Company”), a privately-held proteomics company based in Fremont, California.

24 Oct 2009

Nutri5, an effective natural product for the relief of menopausal symptoms

Earlier this year, the BBC reported that "HRT - Hormone Replacement Therapy - can shrink women's brains"1, after a study was published which showed that brain volume in women taking HRT was smaller in two key areas involved in thinking and memory.

23 Oct 2009

Brain inflammation not linked to Alzheimer's disease

In a surprising reversal of long-standing scientific belief, researchers at the Mayo Clinic campus in Florida have discovered that inflammation in the brain is not the trigger that leads to buildup of amyloid deposits and development of Alzheimer's disease.

23 Oct 2009

Alzheimer's Association appreciates RCN for its generous donation and awareness campaign

RCN Corporation recently donated more than $10,000 towards the Alzheimer's Association, National Capital Area Chapter's Reflections campaign and the nonprofit's signature event, the National Memory Walk. Earlier in the year, the company committed $210,000 in donated cable time for cross-channel spots about local Alzheimer initiatives in 2009.

23 Oct 2009

Aethlon Medical establishes ESI as a wholly owned subsidiary

Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) announced today that it has established Exosome Sciences, Inc. (ESI) as a wholly owned subsidiary of the Company.

23 Oct 2009

Amorfix Life Sciences signs sale and distribution agreement with Cedarlane Laboratories

Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases, announced today that it has signed an agreement with Cedarlane Laboratories for the sale and distribution of Amorfix's proprietary antibodies and reagents.

22 Oct 2009

Alzheimer's Association Comfort Zone launched

Launched today, the Alzheimer's Association Comfort Zone(TM), powered by Omnilink, is the first comprehensive location management system designed specifically for Alzheimer's, giving people with the disease more freedom and independence in their community while providing their family some peace of mind.

22 Oct 2009

Blood test to identify MCI patients at risk of Alzheimer's disease

Elderly people exhibiting memory disturbances that do not affect their normal, daily life suffer from a condition called "mild cognitive impairment" (MCI). Some MCI patients go on to develop Alzheimer's disease within a few years, whereas other cases remain stable, exhibiting only benign senile forgetfulness. It is crucial to develop simple, blood-based tests enabling early identification of these patients that will progress in order to begin therapy as soon as possible, potentially delaying the onset of dementia.

22 Oct 2009

Eyes may mirror Alzheimer's disease

The eyes may be the windows to the soul, but new research indicates they also may mirror a brain ravaged by Alzheimer's disease.

22 Oct 2009

Contribution of glycosaminoglycans to skeletal abnormalities in patients with lysosomal storage diseases demonstrated

A group led by Dr. Dieter Br-mme at the University of British Columbia has demonstrated that glycosaminoglycans (GAGs) contribute to skeletal abnormalities in patients with lysosomal storage diseases. Their report can be found in the November 2009 issue of The American Journal of Pathology.

21 Oct 2009

MMPF technique for diagnosing and predicting brain syndromes

NASA technology will now be available to the medical community to help in the diagnosis and prediction of syndromes that affect the brain, such as stroke, dementia, and traumatic brain injury.

21 Oct 2009

AFFiRiS reports encouraging results from clinical studies of its two Alzheimer's vaccines

AFFiRiS AG today announced that the primary endpoints have been met for the Phase I clinical studies of its two Alzheimer's vaccines AD01 and AD02, which demonstrated favourable safety and tolerability profiles. These results trigger a 10 million EUR milestone payment from licensee GlaxoSmithKline Biologicals.

21 Oct 2009

On-line portal for training doctors and nurses on fall prevention and protection

Medical Nurse Training, Inc. (www.MedicalNurseTraining.com) is the premier on-line portal for training doctors and nurses on fall prevention and protection.

20 Oct 2009

Targacept presents data from Phase 2b clinical trial of TC-5214

Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics-, today announced the presentation of data from its recently completed Phase 2b clinical trial of TC-5214 as an augmentation (add-on) treatment in subjects with major depressive disorder, or MDD, who did not respond adequately to first-line treatment with the representative SSRI citalopram hydrobromide.

20 Oct 2009

Researchers use biotechnological tools to find a cure for Alzheimer's disease

No one has yet found a cure or a way to prevent people from developing Alzheimer's disease. Researchers from the Swedish University of Agricultural Sciences, among others, are breaking new ground in biotechnology to find new tools that can help provide new solutions.

20 Oct 2009

Conference to discuss the pent-up demand for home based eldercare personal robots

GeckoSystems Intl. Corp. announced today that during their first annual "Mobile Robots in Motion" conference November 4-5, 2009, attendees will be able to learn and discuss the basis for GeckoSystems' belief that pent-up demand exists for their cost effective, home based eldercare personal robots.

20 Oct 2009

PhRMA calls for appropriate incentives for continued biotechnology innovation

Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson issued the following statement today regarding appropriate incentives for continued biotechnology innovation:

20 Oct 2009

Scientists find mechanism that protects neurons from calcium overload

Tsuruta et al. find that a lipid kinase directs a voltage-gated calcium channel's degradation to save neurons from a lethal dose of overexcitement. The study appears in the October 19, 2009 issue of the Journal of Cell Biology (www.jcb.org).

20 Oct 2009

Researchers develop new technique to study the mechanisms behind diseases in more detail

Researchers have previously been able to analyse which sugar structures are to be found on certain proteins, but not exactly where on the protein they are positioned. This is now possible thanks to a new technique developed at the Sahlgrenska Academy at the University of Gothenburg, Sweden.

20 Oct 2009

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Los Angeles Jewish Home continues to meet nursing shortage in the country

Eurogentec to acquire Anaspec, a private proteomics company in California

Nutri5, an effective natural product for the relief of menopausal symptoms

Brain inflammation not linked to Alzheimer's disease

Alzheimer's Association appreciates RCN for its generous donation and awareness campaign

Aethlon Medical establishes ESI as a wholly owned subsidiary

Amorfix Life Sciences signs sale and distribution agreement with Cedarlane Laboratories

Alzheimer's Association Comfort Zone launched

Blood test to identify MCI patients at risk of Alzheimer's disease

Eyes may mirror Alzheimer's disease

Contribution of glycosaminoglycans to skeletal abnormalities in patients with lysosomal storage diseases demonstrated

MMPF technique for diagnosing and predicting brain syndromes

AFFiRiS reports encouraging results from clinical studies of its two Alzheimer's vaccines

On-line portal for training doctors and nurses on fall prevention and protection

Targacept presents data from Phase 2b clinical trial of TC-5214

Researchers use biotechnological tools to find a cure for Alzheimer's disease

Conference to discuss the pent-up demand for home based eldercare personal robots

PhRMA calls for appropriate incentives for continued biotechnology innovation

Scientists find mechanism that protects neurons from calcium overload

Researchers develop new technique to study the mechanisms behind diseases in more detail

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in